$MDWD News

Oppenheimer Maintains Outperform on MediWound, Lowers Price Target to $32

HC Wainwright & Co. Reiterates Buy on MediWound, Maintains $36 Price Target

MediWound Ltd. (MDWD) Q1 2026 Earnings Call Transcript

MediWound Ltd. (NASDAQ:MDWD) Q1 2026: Revenue Miss but Narrower Loss, Full-Year Outlook Intact

MediWound Reports Q1 2026 Results: Full Earnings Call Transcript

MediWound Affirms FY2026 Sales Guidance of $24.000M-$26.000M vs $24.759M Est

MediWound Q1 EPS $(0.23) Beats $(0.64) Estimate, Sales $1.475M Miss $3.117M Estimate

MediWound Ltd. (MDWD) Presents at European Wound Management Association (EWMA) 2026 - Slideshow

Newly Published U.S. Expert Consensus Aligns with MediWound’s Strategy for Chronic Wound Debridement

MediWound to Present New EscharEx® Data at Leading Wound Care Conferences

CORRECTION: MediWound To Showcase New Wound Healing Data Across 3 Global Conferences, EscharEx Study Results Back Late-Stage Trials And Expansion Into Diabetic Ulcers

CORRECTION: MediWound To Showcase New Wound Healing Data Across 3 Global Conferences, EscharEx Study Results Back Late-Stage Trials And Expansion Into Diabetic Ulcers

MediWound Q4 Earnings Call Highlights

MediWound Files Annual Report on Form 20-F

MediWound Ltd. Q4 2025 Earnings Call Summary

MediWound Ltd. (MDWD) Q4 2025 Earnings Call Transcript

MediWound (MDWD) Q4 2025 Earnings Call Transcript

MediWound Ltd. (NASDAQ:MDWD) Reports Q4 2025 Revenue Miss Despite Pipeline Progress

MediWound (MDWD) Reports Q4 Loss, Lags Revenue Estimates

MediWound: Q4 Earnings Snapshot